Blood pressure fluctuation and hypertension in patients with Parkinson s disease

Similar documents
Clinical Study Nondipping in Parkinson s Disease

Multiple choice questions: ANSWERS

Središnja medicinska knjižnica

ORTHOSTATIC INTOLERANCE AN EXPRESSION OF AUTONOMIC DISFUNCTION IN PARKINSON S DISEASE

JMD. Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson s Disease ORIGINAL ARTICLE

DIFFERENTIAL DIAGNOSIS SARAH MARRINAN

Parkinson s Disease in the Elderly A Physicians perspective. Dr John Coyle

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

10th Medicine Review Course st July Prakash Kumar

Re-Submission. Scottish Medicines Consortium. rasagiline 1mg tablet (Azilect ) (No. 255/06) Lundbeck Ltd / Teva Pharmaceuticals Ltd.

Cardiovagal Baroreflex Sensitivity in Parkinson s Disease and Multiple-System Atrophy

Faculty. Joseph Friedman, MD

Parkinson s Disease. Gillian Sare

Non-dipping nocturnal blood pressure and psychosis parameters in Parkinson`s Disease

Let s Look at Parkinson s (PD) Sheena Morgan Parkinson s Disease Nurse Specialist Isle of Wight NHS Trust November 2016

PARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease

WHAT DEFINES YOPD? HANDLING UNIQUE CONCERNS REBECCA GILBERT, MD, PHD VICE PRESIDENT, CHIEF SCIENTIFIC OFFICER, APDA MARCH 14, 2019

III./3.1. Movement disorders with akinetic rigid symptoms

Evaluation of Parkinson s Patients and Primary Care Providers

The Direct Cost of Parkinson Disease at Juntendo Medical University Hospital, Japan

Dr Barry Snow. Neurologist Auckland District Health Board

Treatment of Parkinson s Disease: Present and Future

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Parkinson s Disease Current Treatment Options

Revised criteria for the clinical diagnosis of dementia with Lewy. Dementia with Lewy bodies. (Dementia with Lewy Bodies)

Non-motor symptoms in Thai Parkinson s disease patients: Prevalence and associated factors

Joint Session with ACOFP and Mayo Clinic. Parkinson's Disease: 5 Pearls. Jay Van Gerpen, MD

Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs

Clinical Differences Among Four Common Dementia Syndromes. a program of Morningside Ministries

La neurosonologia. Ecografia cerebrale e nuove applicazioni nelle malattie neurodegenerative. Nelle patologie degenerative e vascolari cerebrali

Parkinsonian Disorders with Dementia

Slide notes: References:

Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE

Parkinson s Disease. Sirilak yimcharoen

Drugs used in Parkinsonism

Pa t h w a y s. Pa r k i n s o n s. MacMahon D.G. Thomas S. Fletcher P. Lee M. 2006

Appendix N: Research recommendations

The Spectrum of Lewy Body Disease: Dementia with Lewy Bodies and Parkinson's Disease Dementia

Exercise hemodynamics in Parkinson s Disease and autonomic dysfunction

A prospective study of dementia with Lewy bodies

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension

Enhanced Primary Care Pathway: Parkinson s Disease

Dementia: It s Not Always Alzheimer s

Diagnosing and Treating Neurogenic Orthostatic Hypotension: A Case Study

Northera (droxidopa)

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

UNDERSTANDING PARKINSON S DISEASE

Basal ganglia motor circuit

Clinical Features and Treatment of Parkinson s Disease

The PD You Don t See: Cognitive and Non-motor Symptoms

The Use of Amantadine HCL in Clinical Practice: A Study of Old and New Indications

Welcome and Introductions

Impact of insufficient drug efficacy of antiparkinson agents on patient s quality of life: a cross-sectional study

Non-Motor Symptoms of Parkinson s Disease

Sistema Nervoso Vegetativo Vademecum per la diagnosi differenziale

Parkinson s Disease: initial diagnosis, initial treatment & non-motor features. J. Timothy Greenamyre, MD, PhD

Parkinson s Disease WHERE HAVE WE BEEN, WHERE ARE WE HEADING? CHARLECE HUGHES D.O.

Prior Authorization with Quantity Limit Program Summary

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Differential Diagnosis of Hypokinetic Movement Disorders

The PD You Don t See: Cognitive and Non-motor Symptoms

Evaluation and Management of Parkinson s Disease in the Older Patient

Transcranial sonography in movement disorders

Date of Referral: Enhanced Primary Care Pathway: Parkinson s Disease

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

F indings or symptoms of autonomic dysfunction are

Any interventions, where RCTs in PD are not available, are not included in the tables.

6/13/2017 PROFESSOR CHRISTOPHER J MATHIAS. Non-motor features in PD AUTONOMIC NERVOUS SYSTEM. Motor. Non-Motor CLINICAL AUTONOMIC MANIFESTATIONS

Non-motor subtypes of Early Parkinson Disease in the Parkinson s Progression Markers Initiative

European Commission approves ONGENTYS (opicapone) a novel treatment for Parkinson s disease patients with motor fluctuations

Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University

Optimizing Clinical Communication in Parkinson s Disease:

HM2008/00566/00. study and to obtain clinical experience with the use of this drug. Primary Outcome/Efficacy Variable(s): <Pharmacokinetics>

Comparison of the Assessment of Orthostatic Hypotension Using Peripheral and Central Blood Pressure Measurements

Is Safinamide Effective as an Add-on Medication in Treating Parkinson's Disease Motor Symptoms?

ORIGINAL CONTRIBUTION

ANTIHYPERTENSIVE DRUG THERAPY IN CONSIDERATION OF CIRCADIAN BLOOD PRESSURE VARIATION*

Evaluating the Driving Ability in Patients with Parkinson s Disease Using a Driving Simulator

Managing Movement Disorders in the older patient

Parkinson s Disease Update. Presented by Joanna O Leary, MD Movement disorder neurologist Providence St. Vincent s

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Drug Therapy of Parkinsonism. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Non Alzheimer Dementias

Assessment Toolkits for Lewy Body Dementia

Parkinson s Disease. Prevalence. Mark S. Baron, M.D. Cardinal Features. Clinical Characteristics. Not Just a Movement Disorder

Rasagiline and Rapid Symptomatic Motor Effect in Parkinson s Disease: Review of Literature

Behavioral Aspects of Parkinson s Disease

How to Diagnose Early (Prodromal) Lewy Body Dementia. Ian McKeith MD, FRCPsych, F Med Sci.

Parkinson s Disease Update

Dementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE

Parkinson s Disease Medications: Professionals Edition

Dementia Diagnosis Guidelines Primary Care

PARKINSON S PRIMER. Dr. Kathryn Giles MD, MSc, FRCPC Cambridge, Ontario, Canada

Update on functional brain imaging in Movement Disorders

:{ic0fp'16. Geriatric Medicine: Blood Pressure Monitoring in the Elderly. Terrie Ginsberg, DO, FACOI

Scottish Medicines Consortium

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology

PD: Key Treatment Considerations

Commonly encountered medications and their side effects - what the generalist needs to know

Transcription:

Blood pressure fluctuation and hypertension in patients with Parkinson s disease Tetsuro Tsukamoto 1, Yoshimi Kitano 2 & Sadako Kuno 3 1 Department of Neurology, Numazu Rehabilitation Hospital, 2510-22 Kamikanuki-mandagahara, Numazu, Shizuoka-ken 410-0813, Japan 2 Department of Laboratory, Numazu Rehabilitation Hospital, 2510-22 Kamikanuki-mandagahara, Numazu, Shizuoka-ken 410-0813, Japan 3 Department of Neurology, Kyoto Shijo Hospital, 272-6 Shijohorikawamachi, Higashihorikawadori-shijoukudaru, Shimokyoku, Kyoto 600-0000, Japan Keywords 24-h ABPM, autonomic dysfunction, fluctuating blood pressure, hypertension, Parkinson s disease Correspondence Tetsuro Tsukamoto, Department of Neurology, Numazu Rehabilitation Hospital, 2510-22 Kamikanuki-mandagahara, Numazu, Shizuoka-ken, 410-0813 Japan. Tel: +81-55-931-1911; Fax: +81-55-934-3811; E-mail: rstcp141@yahoo.co.jp Funding Information No funding information provided. Received: 28 May 2013; Revised: 2 September 2013; Accepted: 2 September 2013 Brain and Behavior 2013; 3(6): 710 714 doi: 10.1002/brb3.179 Abstract Objectives: Blood pressure (BP) abnormalities have been known in Parkinson s disease (PD) patients. The present study aimed at determining how the BPs of PD patients fluctuate in a day. Methods: A total of 37 PD patients and 44 OD (other disease) patients, all of who were inpatients, were monitored every 30 min by 24-h ambulatory blood pressure monitoring (ABPM). Results: The average systolic BP and the number of patients who showed postprandial hypotension were not different between the two groups. However, occurrence of nocturnal hypertension, BP fluctuation of over 100 mmhg in a day and BP of over 200 mmhg were significantly more frequently observed in the PD patients than in the OD patients. In the PD patients, these parameters were not different between those who were suffering from the disease for less than 10 years and those with the disease for 10 years or longer, as well as between those who had a Hoehn Yahr staging scale of 2 3 and those with a scale of 4 5. Conclusion: Twenty-four-hour ABPM, not BP measurement once a day, enables us to determine the actual BP in PD patients. Although hypotension is a severe risk factor for falling and syncope, we emphasize the importance of monitoring rather hypertension and fluctuating BP in PD patients that may lead to a variety of other undesirable conditions. Management of hypotension, hypertension, and BP fluctuation is an important issue in the future. Introduction In addition to the motor dysfunctions caused by Parkinson s disease (PD) (e.g., resting tremor, muscle rigidity, bradykinesia, and postural instability), nonmotor dysfunctions such as psychiatric symptoms, dementia, sleep disorders, pains, and autonomic dysfunctions have recently been recognized (Ziemssen and Reichmann 2010; Jain 2011). Among various autonomic dysfunctions in PD, blood pressure (BP) abnormalities such as orthostatic hypotension (Gross et al. 1972; Goldstein et al. 2005; Ziemssen and Reichmann 2010; Sharabi and Goldstein 2011), postprandial hypotension (Ejaz et al. 2006; Luciano et al. 2010), and nocturnal hypertension (Ejaz et al. 2006; Ziemssen and Reichmann 2010; Sharabi and Goldstein 2011; Sommer et al. 2011) are known. However, medical personnel working in hospitals, nursing homes, visiting nursing, or group services often identify extreme BP fluctuations in PD patients and are troubled by excessively high or low BP which occasionally accompanies syncope, while most patients rarely complain of any symptom associated with such abnormal BP (Stuebner et al. 2013). In order to determine how the BPs of PD patients fluctuate in a day, we performed 24-h ambulatory blood pressure monitoring (ABPM) (Mallion et al. 1999). With regard to the BP abnormalities in PD patients, there are several published studies that principally emphasize the importance of monitoring nocturnal hypertension, postprandial hypotension, and orthostatic hypotension (Senard et al. 1992; Ejaz et al. 2006; Schmidt et al. 2009; Stuebner et al. 2013). The present study demonstrates that the BPs of the PD patients fluctuate greatly 710 ª 2013 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

T. Tsukamoto et al. Blood Pressure Fluctuation in Parkinson s Disease in the range of 100 mmhg in a day, occasionally exceeding 200 mmhg. The PD patients in this study included those who were having Parkinson s disease (PD), Parkinson s disease with dementia (PDD), or dementia with Lewy bodies (DLB). All the patients with PDD or DLB began with PD and had been treated for a long period as PD, and later advanced to have cognitive impairment, or fluctuating consciousness or psychosis such as hallucination and delusion. No patient with DLB began with dementia in this study. Recently PD, PDD, and DLB are each considered to be synucleinopathy as a disease entity (van den Berge et al. 2012; Kitao et al. 2013; Kubo and Hattori 2013). The ABPM was performed in the hospitalized condition. In a home setting, BP is influenced by various daily stimuli and, therefore, the assessment of BP fluctuation may be more difficult. Methods ABPM was performed every 30 min for 24 h using TM-2431 (A & D Company, Limited, Tokyo, Japan). A laboratory technical officer mounted a cuff on an upper arm of the respective patients and BP was recorded automatically. The daily activities of the patients such as rising, going to bed, taking meals, and exercising were recorded by attending nurses. Examined were 37 PD patients including those who were having PD, PDD, or DLB. All the patients with PDD or DLB began with PD as mentioned above. The average Hoehn Yahr staging scale of the PD patients was 3.9 (2 5). Also examined were 44 patients with other diseases (OD) such as cerebrovascular disease, femoral neck fracture, myasthenia gravis, and Guillain Barre syndrome, who were not healthy and hospitalized for rehabilitation. All the patients examined were inpatients and were selected because they had no acute illness. The control subjects had various diseases and some of them could have autonomic dysfunction. They were transferred to our hospital for rehabilitation after having been treated at the respective previous hospitals and were already in a chronic and stable state. They did not complain of any symptom related to BP abnormality. The average age of the patients with PD and that of the patients with OD were 75.2 (46 91) and 72.6 (39 85), respectively. Further, the gender ratio of these two groups (male:female) was 18:19 and 20:24, respectively (Table 1). Nocturnal hypertension was defined as a condition where a nocturnal supine BP (from 7 PM to 6 AM) was higher than a daytime BP. Postprandial hypotension was defined as a condition where a systolic BP was lower than 20 mmhg within 90 min after the beginning of a meal that was observed at least twice in three meals. The patients with percutaneous endoscopic gastrostomy (nine patients with PD and one patient with OD) were excluded for assessing postprandial hypotension. A ΔBP of over 100 mmhg (ΔBP > 100 mmhg) was defined as a condition where the systolic BP fluctuation was greater than 100 mmhg in a given period of 24 h. Statistical analyses were performed by using Welch s t test and Fisher s exact probability test. Results Nocturnal hypertension was observed in 64.9% of the patients with PD and 18.2% of the patients with OD. Postprandial hypotension was observed in 71.4% of the patients with PD and 51.2% of the patients with OD. A BP fluctuation of over 100 mmhg (ΔBP > 100 mmhg) was observed in 67.6% of the patients with PD, but only in 13.6% of the patients with OD. A BP of over 200 mmhg (BP > 200 mmhg) was observed in a period of 1 day in 35.1% of the patients with PD and 13.6% of the patients with OD. The statistical analysis with Welch s t test showed no significant difference in the average BPs between the two groups, but the highest systolic BP during the monitoring was higher in the PD patients (average standard deviation = 194 23 mmhg) than in the OD patients (177 24 mmhg) (P < 0.05) and the lowest systolic BP was lower in the patients with PD (89 14 mmhg) than in the patients with OD (97 15 mmhg) (P < 0.05). Furthermore, Fisher s exact probability test demonstrated that nocturnal hypertension (P < 0.001), ΔBP > 100 mmhg (P < 0.001), and BP > 200 mmhg Table 1. The number of patients, gender ratio, average age, Hoehn Yahr staging scale (H-Y), average systolic BP, and the standard deviation (SD) of the systolic BP. Disease No. of patients Gender (M/F) Age H-Y Average systolic BP SD PD 37 18/19 75.2 (46 91) 3.9 (2 5) 133.7 18.8 mmhg OD 44 20/24 72.6 (39 89) 129.1 14.8 mmhg P 0.234 PD, Parkinson s disease; OD, other diseases. ª 2013 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. 711

Blood Pressure Fluctuation in Parkinson s Disease T. Tsukamoto et al. Table 2. BP fluctuation, hypertension of over 200 mmhg, nocturnal hypertension, and postprandial hypotension in PD patients and OD patients. Diseases ΔBP > 100 mmhg BP > 200 mmhg NH PH PD 24/37 (64.9%) 13/37 (35.1%) 24/37 (64.9%) 20/28 (71.4%) OD 6/44 (13.6%) 6/44 (13.6%) 8/44 (18.2%) 22/43 (51.2%) P <0.001 <0.05 <0.001 0.073 ΔBP > 100 mmhg, systolic BP fluctuation of over 100 mmhg in 24 h; BP > 200 mmhg, systolic BP of over 200 mmhg in 24 h; NH, nocturnal hypertension; PH, postprandial hypotension. Table 3. BP data of PD patients who were suffering from the diseases for less than 10 years or for 10 years or longer. Duration No. of patients Average systolic BP SD ΔBP > 100 mmhg BP > 200 mmhg Less than 9 years 19 (51.4%) 137.7 21.9 14/19 (73.7%) 8/19 (42.1%) 10 years or longer 18 (48.6%) 128.9 13.9 10/18 (55.6%) 5/18 (27.8%) P 0.153 0.209 0.286 Table 4. BP data of PD patients who had a Hoehn Yahr scale (H-Y) of 2 3 or4 5. H-Y scale No. of patients Average systolic BP SD ΔBP > 100 mmhg BP > 200 mmhg H-Y 2 3 13 (35.1%) 128.8 12.8 7/13 (53.8%) 4/13 (30.8%) H-Y 4 5 24 (64.9%) 136 21.1 17/24 (70.8%) 9/24 (37.5%) P 0.204 0.687 0.485 (P < 0.05) were observed significantly more often in the patients with PD than in the patients with OD. There was no significant difference between the two groups of patients in terms of postprandial hypotension, although the patients with PD tended to develop postprandial hypotension more often (71.4%) than the patients with OD (51.2%) (Tables 1 and 2). In the PD patients, these parameters were not different between those who were suffering from the disease for less than 10 years and those with the disease for 10 years or longer, as well as between those who had a Hoehn Yahr staging scale of 2 3 and those with a scale of 4 5 (Tables 3 and 4). During the examination, no patient developed syncope, dizziness, or any other symptoms related to the BP change. Prescribed drugs for the patients with PD were l-dopa, dopamine agonists, selegiline, entacapon, zonisamide, and/or L-threo-DOPS. No patient received fludrocortisone. The relationships between the BP and the respective drugs prescribed for PD, however, were not clear due to the small number of the examined patients and occurrence of unpredictable BP fluctuation. Discussion As conventionally known, the PD patients exhibited a tendency to develop orthostatic hypotension (Gross et al. 1972; Goldstein et al. 2005; Ziemssen and Reichmann 2010; Sharabi and Goldstein 2011), postprandial hypotension (Ejaz et al. 2006; Luciano et al. 2010), and nocturnal hypertension (Ejaz et al. 2006; Ziemssen and Reichmann 2010; Sharabi and Goldstein 2011; Sommer et al. 2011). Although orthostatic hypotension may be a risk factor leading to dizziness, syncope, and falling, many patients are known to be asymptomatic (Stuebner et al. 2013). Importantly, in the present study, the PD patients were found to experience considerable intraday BP fluctuation, and there were observed many cases where the fluctuation was larger than 100 mmhg in terms of the difference between the highest and the lowest systolic blood pressures. Furthermore, although the average BP of the PD patients was not significantly different from that of the control patients, the highest systolic BP during the monitoring was higher in the PD patients than in the OD patients and the lowest systolic BP was lower in the PD patients than in the OD patients, suggesting that the PD patients experience greater BP fluctuations. Such larger BP fluctuations may confuse attending medical personnel who happen to notice a high or low abnormal BP in patients. In addition, it is intriguing that some of the patients in the advanced stage lying in bed all day long also showed large BP fluctuations, suggesting that the cardiovascular autonomic function is severely impaired and BP regulation is lost in these patients. 712 ª 2013 The Authors. Brain and Behavior published by Wiley Periodicals, Inc.

T. Tsukamoto et al. Blood Pressure Fluctuation in Parkinson s Disease In the treatment of PD, conventionally, occurrence of low BP has been regarded as a problem (Ziemssen and Reichmann 2010; Jain 2011; Sharabi and Goldstein 2011); however, the present study found that the PD patients frequently experience a high BP of 200 mmhg or higher, which indicates that they may potentially be subjected to risks of high BP several times a day. Such a condition may go unnoticed over a prolonged period of time because mere routine BP measurement performed once a day or so is unable to determine their exact BP changes (Mallion et al. 1999; White et al. 2011). Ziemssen and Reichmann (2010) provide an example of ABPM in a PD patient, which also shows BP fluctuations and occurrence of a high BP of over 200 mmhg during night. A prominent BP fluctuation accompanying hypertension may potentially induce cerebral stroke, cardiovascular disorder, and/or organopathy; therefore, it is rather required to select a drug capable of stabilizing the BP (Parati and Mancia 2001; Brickman et al. 2010). In terms of the average BP, ΔBP > 100 mmhg, and BP > 200 mmhg, there was no significant difference between the PD patients who were suffering from the disease for less than 10 years and those with the disease for 10 years or longer as well as between those who had a Hoehn Yahr staging scale of 2 3 and those with a scale of 4 5. This suggests that the autonomic dysfunction may even begin in the early stage of the disease (Asahina et al. 2013; Stuebner et al. 2013); however, as this study was performed only for inpatients whose disease conditions had fairly advanced and the sample size was small, it is yet to be determined as to how the BP fluctuates in an earlier stage of the illness. Furthermore, the reason why abnormal BP fluctuations were frequently observed even in the control subjects is speculated to be because they were inpatients and aged (Haensch and Jorg 2005; Stuebner et al. 2013), that is, not completely healthy individuals who were suffering from cerebrovascular disease and the like. As the control group, the use of healthy controls would have been better suited for evaluating the difference between the disease and the health, and if healthy controls were assessed, the difference could have been more prominent and more accurately identified, but it is not practical to gather aged healthy individuals and evaluate them in the hospital. Furthermore, most aged individuals may already have some diseases and have autonomic dysfunction to some extent (Haensch and Jorg 2005; Stuebner et al. 2013). In conclusion, we emphasize that rather hypertension and fluctuating BP, which may lead to a variety of other undesirable conditions (Parati and Mancia 2001; Brickman et al. 2010), should be monitored in PD patients, even though hypotension in PD is a severe risk factor for falling and syncope. Management of hypotension, hypertension, and BP fluctuation is an important issue in the future. Conflict of Interest None declared. References Asahina, M., E. Vichayanrat, D. A. Low, V. Iodice, and C. J. Mathias. 2013. Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology. J. Neurol. Neurosurg. Psychiatry 84:674 680. van den Berge, S. A., J. T. Kevenaar, J. A. Sluijs, and E. M. Hol. 2012. Dementia in Parkinson s disease correlates with alph-synuclein pathology but not with cortical astrogliosis. Parkinsons Dis. 2012:420957. Brickman, A. M., C. Reitz, J. A. Luchsinger, J. J. Manly, N. Schupf, J. Muraskin, et al. 2010. Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch. Neurol. 67:564 569. Ejaz, A. A., I. S. Sekhon, and S. Munjal. 2006. Characteristic findings on 24-h ambulatory blood pressure monitoring in a series of patients with Parkinson s disease. Eur. J. Inter. Med. 17:417 420. Goldstein, D. S., B. A. Eldadah, C. Holmes, S. Pechnik, J. Moak, A. Saleem, et al. 2005. Neurocirculatory abnormalities in Parkinson s disease with orthostatic hypotension: independence from levodopa treatment. Herpertens 46:1333 1339. Gross, M., R. Bannister, and R. Godwin-Austen. 1972. Orthostatic hypotension in Parkinson s disease. Lancet 1:174 176. Haensch, C. A., and J. Jorg. 2005. Schwindel und Synkope bei Polyneuropathies im Alter. Eur. J. Geriatr. 7:167 173. Jain, S. 2011. Multi-organ autonomic dysfunction in Parkinson disease. Parkinsonism Relat. Disord. 17:77 83. Kitao, S., E. Matsusue, S. Fujii, F. Miyoshi, T. Kaminou, S. Kato, et al. 2013. Correlation between pathology and neuromelanin MR imaging in Parkinson s disease and dementia with Lewy bodies. Neuroradiology 55:947 953. Kubo, S., and N. Hattori. 2013. Can synucleinopathy and tauopathy be identified during life? Nat. Rev. Neurol. 9:426 427. Luciano, G. L., M. J. Brennan, and M. B. Rothberg. 2010. Postprandial hypotension. Am. J. Med. 123:281. e1 281. e6. Mallion, J. M., J. P. Baquet, J. P. Siche, F. Tremel, and R. De Gaudemaris. 1999. Clinical value of ambulatory blood pressure monitoring. J. Hypertens. 17:585 595. Parati, G., and G. Mancia. 2001. Blood pressure variability as a risk factor. Blood Press. Monit. 6:341 347. Schmidt, C., D. Berg, S. Prieur, S. Prieur, S. Junghanns, K. Schweitzer, et al. 2009. Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. Mov. Disord. 24:2136 2141. ª 2013 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. 713

Blood Pressure Fluctuation in Parkinson s Disease T. Tsukamoto et al. Senard, J. M., B. Chamontin, A. Rascol, and J. L. Montastruc. 1992. Ambulatory blood pressure in patients with Parkinson s disease without and with orthostatic hypotension. Clin. Auto. Res. 2:99 104. Sharabi, Y., and D. S. Goldstein. 2011. Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease. J. Neurol. Sci. 310:123 128. Sommer, S., B. Aral-Becher, and W. Jost. 2011. Nondipping in Parkinson s disease. Parkinsons Dis. 2011:897586. Stuebner, E., E. Vichayanrat, D. A. Low, C. J. Mathias, S. Isenmann, and C. A. Haensch. 2013. Twenty-four hour non-invasive ambulatory blood pressure and heart rate monitoring in Parkinson s disease. Front. Neurol. 4:49. White, W. B., L. Wolfson, D. B. Wakefield, C. B. Hall, P. Campbell, N. Moscufo, et al. 2011. Average daily blood pressure, not official blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people. Hypertension 124:2312 2319. Ziemssen, T., and H. Reichmann. 2010. Cardiovascular autonomic dysfunctions in PD. J. Neurol. Sci. 289:74 80. 714 ª 2013 The Authors. Brain and Behavior published by Wiley Periodicals, Inc.